ALFA Finder| Revenue growth | 24% Q4 growth; 12% for full year FY26. |
|---|---|
| Margins | EBITDA margin stable at 31.5% for Q4 and 32% for FY26. |
| Demand visibility | Strong demand in Bengaluru and NCR; maternity and pediatrics stable. |
| Management confidence | Balanced and execution-focused with new CEO transitioning smoothly. |
Growth
FY26 revenue hit ₹1,703cr with 12% growth; Q4 growth peaked at 24% driven by mature and new hospital traction.
Outlook
Management guides for 20% growth in FY27; nearly 900 beds currently in the execution pipeline over 2.5 years.
Risks
Seasonal dependency remains high; recent large-scale bed additions could pressure margins if occupancy ramp-up lags expectations.
Earnings Call filed with NSE, NSE: RAINBOW. Summary written with AI assistance from the document.
Rainbow Childrens Medicare Ltd: key numbers
- Share price
- ₹1,284.50
- Market cap
- ₹13,046 Cr
- Revenue (annual)
- ₹1,703 Cr
- Net profit (annual)
- ₹278.3 Cr
- P/E (TTM)
- 44.6×Sector 54.5×
- Promoter holding
- 49.83%-0.01% QoQ
- FII holding
- 14.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rainbow Childrens Medicare Ltd
All →Rainbow Childrens Medicare Earnings Call Transcript: Key Takeaways
Rainbow delivered robust 23.2% revenue growth despite a soft monsoon impacting seasonal pediatric volumes.
- Call
- Guides 18% growth
Rainbow Childrens Medicare Results Update
Rainbow Children's Medicare reported Q2 FY27 revenue of Rs. 5,480 Mn, up 23% YoY, with PAT of Rs. 839 Mn. Nellore and Guntur hospitals commenced operations during the quarter.
- hospital beds
- 120.0 beds
Rainbow Childrens Medicare Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹548 Cr (+23% YoY) and PAT ₹84 Cr (+11%). Post-IndAS EBITDA margin fell to 31.0% from 33.5%. Strategy is hub-and-spoke pediatric and maternity expansion across 26 hospitals.
Rainbow Childrens Medicare Q2 FY27 Results: Net Profit ₹83.9 Cr, Up 11.0% YoY
Rainbow Childrens Medicare Ltd reported revenue from operations of ₹548 Cr (+23.2% YoY) and net profit of ₹83.9 Cr (+11.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹83.9 Cr · +11.0% YoY
Rainbow Childrens Medicare Board Meeting Date
Rainbow Children's Medicare will hold a board meeting on 31-Oct-2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the results.
Rainbow Childrens Medicare Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.